La cadena de opciones muestra datos clave de las opciones de acciones de EverQuote a varios precios de ejercicio y fechas de vencimiento. Los operadores utilizan esta información para analizar posibles operaciones y evaluar el sentimiento del mercado para EverQuote..

EverQuote (NASDAQ:EVER) Bolsa, Cadena de Opciones

EverQuote

EverBank Financial

EverBank Financial Corp.

NYSE

EverQuote Inc is engaged in the business activity of offering an online marketplace for insurance shopping. The online marketplace offers consumers to find relevant insurance quotes based on car insurance, home insurance, and life insurance. The platform of the company is driven by data science. The firm's data and technology platform match and connects consumers seeking to purchase insurance with relevant options from its broad direct network of insurance providers. It derives a majority of revenue from Direct channels.

EverQuote Inc

Everscale

EVERBRIDGE INC COM

EVERBRIGHT SECS CO LTD by EVERBRIGHT SECS CO LTD

EVEREST CONSOLIDATOR ACQUISITION CORP UNIT 1 COM CL A & 1/2 WT EXP

EVERGREEN MARINE CORP by Evergreen Marine Corp. Ltd.

EVERGREEN PRODS GROUP LTD by EVERGREEN PRODS GROUP LTD.

EVER HARVEST INTL GRP by Ever Harvest International Group Inc.

Ever Harvest International Group Inc

EVER-GLORY INTL GROUP INC by Ever-Glory International Group, Inc.

Ever-Glory International Group Inc

EverCommerce Inc

EVERGEN INFRASTRUCTURE CP by EverGen Infrastructure Corp.

EverGen Infrastructure Corp

EverRise

Evercel Inc

Evercore Inc

Everdime Inc

Everest

EVEREST CONSOLIDATOR A by Everest Consolidator Acquisition Corporation

Everest Consolidator Acquisition Corp

Everest Group Ltd

EVEREST METALS CORP LTD by EVEREST METALS CORP LTD.

Everest Metals Corp Ltd

Evergold Corp

EVERGRANDE PPTY UNSP/ADR by Evergrande Property Services Group Limited

Evergrande Property Services Group Ltd

EVERGRANDE PPTY SVC GRP by Evergrande Property Services Group Limited

Evergreen Corp

Evergreen Corporation - Class A Ordinary Share

EVERGREEN PRODS GROUP ADR by Evergreen Products Group Ltd

Evergreen Products Group Ltd

EVERGREEN SUSTAIN ENTPRS by Evergreen Sustainable Enterprises Inc.

Evergreen Sustainable Enterprises Inc

Evergy Inc

Everi Holdings Inc

Everipedia

Everlert Inc

Everock Inc

Eversource Energy

Everspin Technologies, Inc. - Common Stock

Everspin Technologies Inc

Evertec Inc

EVERTZ TECHNOLOGIES LTD by Evertz Technologies Ltd.

Evertz Technologies Ltd

Everus Construction Group, Inc. Common Stock

Everus Construction Group Inc

EVERYBODY LOVES LANGUAGES by EVERYBODY LOVES LANGUAGES CORP.

Everybody Loves Languages Corp

EVERYDAY PEOPLE FINL CORP by Everyday People Financial Corp.

Everyday People Financial Corp

EVERYTHING BLOCKCHAIN INC by EVERYTHING BLOCKCHAIN INC.

Everything Blockchain Inc

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul>
<li>Raymond James analyst C. Gregory Peters upgraded the rating for The Progressive Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PGR#NYSE">PGR</a>) from Market Perform to Outperform and announced a $305 price target. Progressive shares closed at $243.24 on Tuesday. <a href="https://www.benzinga.com/quote/PGR/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Raymond James analyst Aaron Kessler upgraded EverQuote, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EVER#NASDAQ">EVER</a>) from Outperform to Strong Buy and maintained the price target of $35. EverQuote shares closed at $18.32 on Tuesday. <a href="https://www.benzinga.com/quote/EVER/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>HC Wainwright &amp; Co. analyst Raghuram Selvaraju upgraded the rating for RAPT Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RAPT#NASDAQ">RAPT</a>) from Neutral to Buy and maintained the price target of $10. RAPT Therapeutics shares closed at $1.73 on Tuesday. <a href="https://www.benzinga.com/quote/RAPT/analyst-ratings">See how other analysts view this stock</a>.</li>
</ul>
Considering buying PGR stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="598" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/26093624/image-210-1024x598.png" alt="" class="wp-image-707746" style="width:365px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/26093624/image-210-1024x598.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/26093624/image-210-300x175.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/26093624/image-210-768x448.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/26093624/image-210.png 1057w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/24/12/42669200/wall-streets-most-accurate-analysts-give-their-take-on-3-utilities-stocks-with-over-4-dividend-yields">Wall Street&#8217;s Most Accurate Analysts Give Their Take On 3 Utilities Stocks With Over 4% Dividend Yields</a></li>
</ul>

News

Upgrades

Markets

Analyst Ratings

Trading Ideas

EVER

RAPT

This Progressive Analyst Turns Bullish; Here Are Top 3 Upgrades For Thursday

WIIM

EverQuote shares are trading higher after Raymond James upgraded the stock from Outperform to Strong Buy.

Raymond James analyst Aaron Kessler upgrades EverQuote (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EVER#NASDAQ">EVER</a>) from Outperform to Strong Buy and maintains the price target from $35 to $35.

Price Target

Raymond James Upgrades EverQuote to Strong Buy, Maintains Price Target to $35

JP Morgan analyst Cory Carpenter maintains EverQuote (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EVER#NASDAQ">EVER</a>) with a Overweight and lowers the price target from $34 to $28.

JP Morgan Maintains Overweight on EverQuote, Lowers Price Target to $28

B. Riley Securities analyst Daniel Day maintains EverQuote (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EVER#NASDAQ">EVER</a>) with a Buy and lowers the price target from $36.5 to $29.

B. Riley Securities Maintains Buy on EverQuote, Lowers Price Target to $29

<h3>Gainers</h3>
<ul>
<li>QuinStreet (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QNST#NASDAQ">QNST</a>) shares moved upwards by 30.0% to $26.26 during Tuesday's pre-market session. The market value of their outstanding shares is at $1.4 billion. As per the news, the Q1 earnings report came out yesterday. </li>
<li>Vimeo (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VMEO#NASDAQ">VMEO</a>) shares rose 16.83% to $5.62. The company's market cap stands at $931.7 million. As per the press release, Q3 earnings came out yesterday. </li>
<li>Fangdd Network Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DUO#NASDAQ">DUO</a>) stock rose 14.16% to $1.37. The market value of their outstanding shares is at $18.4 million. </li>
<li>EverQuote (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EVER#NASDAQ">EVER</a>) stock increased by 12.88% to $19.54. The company's market cap stands at $678.5 million. The company's, Q3 earnings came out yesterday. </li>
<li>Trump Media &amp; Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DJT#NASDAQ">DJT</a>) shares increased by 9.26% to $37.52. The market value of their outstanding shares is at $7.5 billion. </li>
<li>Kuke Music Hldg (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KUKE#NYSE">KUKE</a>) shares increased by 8.48% to $0.41. The market value of their outstanding shares is at $16.1 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>NFT (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/MI#AMEX">MI</a>) shares decreased by 16.1% to $7.5 during Tuesday's pre-market session. The market value of their outstanding shares is at $23.1 million. </li>
<li>MediaAlpha (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MAX#NYSE">MAX</a>) stock fell 13.31% to $13.94. The company's market cap stands at $768.0 million. As per the news, the Q3 earnings report came out 4 days ago. </li>
<li>Altice USA (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ATUS#NYSE">ATUS</a>) stock declined by 12.75% to $2.26. The market value of their outstanding shares is at $1.0 billion. The company's, Q3 earnings came out yesterday. </li>
<li>Hanryu Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HRYU#NASDAQ">HRYU</a>) stock declined by 9.95% to $0.26. The market value of their outstanding shares is at $13.6 million. </li>
<li>Cineverse (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CNVS#NASDAQ">CNVS</a>) shares decreased by 8.76% to $2.5. The market value of their outstanding shares is at $39.2 million. </li>
<li>BuzzFeed (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BZFD#NASDAQ">BZFD</a>) shares decreased by 6.7% to $2.37. The company's market cap stands at $89.5 million. 
See Also: <a href="http://www.benzinga.com/money/best-communication-services-stocks/" title="www.benzinga.com/money/best-communication-services-stocks/">www.benzinga.com/money/best-communication-services-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Movers

ATUS

BZFD

CNVS

HRYU

KUKE

QNST

VMEO

12 Communication Services Stocks Moving In Tuesday's Pre-Market Session

<h3>Gainers</h3>
<ul>
<li>QuinStreet (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QNST#NASDAQ">QNST</a>) stock rose 30.0% to $26.26 during Tuesday's pre-market session. The company's market cap stands at $1.4 billion. As per the news, the Q1 earnings report came out yesterday. </li>
<li>Vimeo (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VMEO#NASDAQ">VMEO</a>) stock rose 16.83% to $5.62. The company's market cap stands at $931.7 million. As per the press release, Q3 earnings came out yesterday. </li>
<li>Fangdd Network Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DUO#NASDAQ">DUO</a>) stock increased by 14.16% to $1.37. The market value of their outstanding shares is at $18.4 million. </li>
<li>EverQuote (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EVER#NASDAQ">EVER</a>) stock rose 12.88% to $19.54. The market value of their outstanding shares is at $678.5 million. The company's, Q3 earnings came out yesterday. </li>
<li>Trump Media &amp; Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DJT#NASDAQ">DJT</a>) shares rose 9.26% to $37.52. The market value of their outstanding shares is at $7.5 billion. </li>
<li>Kuke Music Hldg (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KUKE#NYSE">KUKE</a>) shares moved upwards by 8.48% to $0.41. The company's market cap stands at $16.1 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>NFT (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/MI#AMEX">MI</a>) shares fell 16.1% to $7.5 during Tuesday's pre-market session. The market value of their outstanding shares is at $23.1 million. </li>
<li>MediaAlpha (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MAX#NYSE">MAX</a>) shares fell 13.31% to $13.94. The company's market cap stands at $768.0 million. As per the news, the Q3 earnings report came out 4 days ago. </li>
<li>Altice USA (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ATUS#NYSE">ATUS</a>) shares decreased by 12.75% to $2.26. The market value of their outstanding shares is at $1.0 billion. The company's, Q3 earnings came out yesterday. </li>
<li>Hanryu Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HRYU#NASDAQ">HRYU</a>) stock decreased by 9.95% to $0.26. The company's market cap stands at $13.6 million. </li>
<li>Cineverse (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CNVS#NASDAQ">CNVS</a>) stock declined by 8.76% to $2.5. The market value of their outstanding shares is at $39.2 million. </li>
<li>BuzzFeed (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BZFD#NASDAQ">BZFD</a>) shares fell 6.7% to $2.37. The market value of their outstanding shares is at $89.5 million. 
See Also: <a href="http://www.benzinga.com/money/best-communication-services-stocks/" title="www.benzinga.com/money/best-communication-services-stocks/">www.benzinga.com/money/best-communication-services-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

EverQuote (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EVER#NASDAQ">EVER</a>) reported quarterly earnings of $0.31 per share which beat the analyst consensus estimate of $0.22 by 40.91 percent. This is a 135.63 percent increase over losses of $(0.87) per share from the same period last year. The company reported quarterly sales of $144.53 million which beat the analyst consensus estimate of $140.34 million by 2.99 percent. This is a 162.73 percent increase over sales of $55.01 million the same period last year.

Earnings

Earnings Beats

EverQuote Q3 EPS $0.31 Beats $0.22 Estimate, Sales $144.53M Beat $140.34M Estimate

EverQuote (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EVER#NASDAQ">EVER</a>) sees Q4 sales of $131.000 million-136.000 million vs $126.18 million estimate.

Guidance

EverQuote Sees Q4 Sales $131.000M-136.000M vs $126.18M Est

<h3>Gainers</h3>
<ul>
<li>Snail (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNAL#NASDAQ">SNAL</a>) stock moved upwards by 5.3% to $2.36 during Monday's after-market session. The company's market cap stands at $86.7 million. </li>
<li>EverQuote (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EVER#NASDAQ">EVER</a>) stock moved upwards by 5.02% to $20.5. The company's market cap stands at $711.8 million. </li>
<li>Fangdd Network Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DUO#NASDAQ">DUO</a>) shares moved upwards by 2.83% to $1.09. The market value of their outstanding shares is at $8.8 million. </li>
<li>MediaCo Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MDIA#NASDAQ">MDIA</a>) shares increased by 2.58% to $1.19. The market value of their outstanding shares is at $55.5 million. </li>
<li>FingerMotion (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FNGR#NASDAQ">FNGR</a>) stock increased by 2.33% to $2.24. The market value of their outstanding shares is at $117.8 million. </li>
<li>BloomZ (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLMZ#NASDAQ">BLMZ</a>) shares moved upwards by 2.29% to $1.34. The market value of their outstanding shares is at $17.9 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Sify Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SIFY#NASDAQ">SIFY</a>) shares fell 5.0% to $3.6 during Monday's after-market session. The market value of their outstanding shares is at $1.5 billion. </li>
<li>HWH International (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HWH#NASDAQ">HWH</a>) stock decreased by 5.0% to $0.78. The company's market cap stands at $17.4 million. </li>
<li>Direct Digital Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DRCT#NASDAQ">DRCT</a>) stock decreased by 4.73% to $3.43. The market value of their outstanding shares is at $49.2 million. </li>
<li>Hanryu Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HRYU#NASDAQ">HRYU</a>) shares decreased by 4.05% to $0.19. The company's market cap stands at $10.0 million. </li>
<li>QMMM Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QMMM#NASDAQ">QMMM</a>) stock decreased by 2.1% to $7.7. The company's market cap stands at $132.4 million. </li>
<li>GD Culture Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GDC#NASDAQ">GDC</a>) stock declined by 1.92% to $2.54. The company's market cap stands at $24.7 million. 
See Also: <a href="http://www.benzinga.com/money/best-communication-services-stocks/" title="www.benzinga.com/money/best-communication-services-stocks/">www.benzinga.com/money/best-communication-services-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

BLMZ

DRCT

FNGR

MDIA

QMMM

SIFY

SNAL

12 Communication Services Stocks Moving In Monday's After-Market Session

JP Morgan analyst Cory Carpenter maintains EverQuote (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EVER#NASDAQ">EVER</a>) with a Overweight and raises the price target from $29 to $34.

JP Morgan Maintains Overweight on EverQuote, Raises Price Target to $34

Craig-Hallum analyst Jason Kreyer maintains EverQuote (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EVER#NASDAQ">EVER</a>) with a Buy and raises the price target from $30 to $33.

Craig-Hallum Maintains Buy on EverQuote, Raises Price Target to $33

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul>
<li>Piper Sandler cut the price target for CrowdStrike Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRWD#NASDAQ">CRWD</a>) from $310 to $290. Piper Sandler analyst Rob Owens upgraded the stock from Neutral to Overweight. CrowdStrike shares gained 1.9% to close at $222.05 on Monday. <a href="https://www.benzinga.com/quote/CRWD/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Deutsche Bank raised the price target for Palantir Technologies Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PLTR#NYSE">PLTR</a>) from $20 to $21. Deutsche Bank analyst Brad Zelnick maintained the stock with a Sell rating. Palantir shares fell 2.6% to close at $24.09 on Monday. <a href="https://www.benzinga.com/quote/PLTR/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Needham cut RxSight, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RXST#NASDAQ">RXST</a>) price target from $75 to $54. Needham analyst David Saxon maintained a Buy rating. RxSight shares fell 2.4% to close at $40.78 on Monday. <a href="https://www.benzinga.com/quote/RXST/analyst-ratings">See how other analysts view this stock.</a></li>
<li>B of A Securities raised the price target for Axsome Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AXSM#NASDAQ">AXSM</a>) from $95 to $106. B of A Securities analyst Jason Gerberry upgraded the stock from Neutral to Buy. Axsome Therapeutics shares fell 1.4% to close at $83.21 on Monday. <a href="https://www.benzinga.com/quote/AXSM/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Baird raised Freshpet, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FRPT#NASDAQ">FRPT</a>) price target from $135 to $140. Baird analyst Peter Benedict maintained an Outperform rating. Freshpet shares fell 0.6% to close at $121.41 on Monday. <a href="https://www.benzinga.com/quote/FRPT/analyst-ratings">See how other analysts view this stock.</a></li>
<li>JP Morgan raised Lithia Motors, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LAD#NYSE">LAD</a>) price target from $280 to $315. JP Morgan analyst Rajat Gupta maintained an Overweight rating. Lithia Motors shares fell 4.6% to close at $276.76 on Monday. <a href="https://www.benzinga.com/quote/LAD/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Needham raised the price target for EverQuote, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EVER#NASDAQ">EVER</a>) from $30 to $38. Needham analyst Mayank Tandon maintained a Buy rating. EverQuote shares fell 3.5% to close at $23.96 on Monday. <a href="https://www.benzinga.com/quote/EVER/analyst-ratings">See how other analysts view this stock.</a></li>
<li>BMO Capital boosted Tyson Foods, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TSN#NYSE">TSN</a>) price target from $58 to $60. BMO Capital analyst Andrew Strelzik maintained a Market Perform rating. Tyson shares rose 2.1% to close at $62.51 on Monday. <a href="https://www.benzinga.com/quote/TSN/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Truist Securities raised eBay Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EBAY#NASDAQ">EBAY</a>) price target from $50 to $58. Truist Securities analyst Youssef Squali maintained a Hold rating. EVgo shares fell 2.7% to close at $54.66 on Monday. <a href="https://www.benzinga.com/quote/EBAY/analyst-ratings">See how other analysts view this stock.</a></li>
<li>JP Morgan raised AutoNation, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AN#NYSE">AN</a>) price target from $155 to $160. JP Morgan analyst Rajat Gupta maintained a Neutral rating. AutoNation shares dipped 2.7% to close at $166.06 on Monday. <a href="https://www.benzinga.com/quote/AN/analyst-ratings">See how other analysts view this stock.</a></li>
</ul>
Read More: 
<ul>
<li><a href="https://www.benzinga.com/news/earnings/24/08/40178833/dow-records-worst-day-in-around-2-years-mag-7-stocks-lose-650b-in-market-capitalization-greed-index">Dow Records Worst Day In Around 2 Years, Mag 7 Stocks Lose $650B In Market Capitalization: Greed Index Moves To &#8216;Extreme Fear&#8217; Zone</a></li>
</ul>

AXSM

CRWD

EBAY

FRPT

PLTR

RXST

Lithia Motors To Rally Around 14%? Here Are 10 Top Analyst Forecasts For Tuesday

EverQuote shares are trading higher after the company reported better-than-expected Q2 financial results and issued Q3 revenue guidance above estimates. Also, Needham maintained a Buy rating on the stock and raised its price target from $30 to $38.

Needham analyst Mayank Tandon maintains EverQuote (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EVER#NASDAQ">EVER</a>) with a Buy and raises the price target from $30 to $38.

Needham Maintains Buy on EverQuote, Raises Price Target to $38

EverQuote (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EVER#NASDAQ">EVER</a>) reported quarterly earnings of $0.17 per share which beat the analyst consensus estimate of $0.03 by 466.67 percent. This is a 160.71 percent increase over losses of $(0.28) per share from the same period last year. The company reported quarterly sales of $117.14 million which beat the analyst consensus estimate of $102.81 million by 13.94 percent. This is a 72.30 percent increase over sales of $67.98 million the same period last year.

EverQuote Q2 EPS $0.17 Beats $0.03 Estimate, Sales $117.14M Beat $102.81M Estimate

Third Quarter&nbsp;2024&nbsp;Outlook:
<ul>
<li>Variable Marketing Margin of&nbsp;$38.5&nbsp;-&nbsp;$41.5 million.</li>
<li>Adjusted EBITDA of&nbsp;$14.0&nbsp;-&nbsp;$17.0 million.</li>
</ul>

EverQuote Expects Q3 Revenue Of $137M - $143M, Est $98.85M

EverQuote shares are trading higher. The company reported Q2 financial results.

MetLife, Inc.&#39;s (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/met#NYSE">MET</a>) institutional asset management arm, MetLife Investment Management (&quot;MIM&quot;), recently launched its second private equity fund, MetLife Investment Private Equity Partners II, securing around $1.2 billion in commitments. This new fund, aimed at institutional clients, includes a portfolio of about $860 million in private equity and co-investment interests. Combined with funded and unfunded commitments, the total reaches $975 million.
The transaction was anchored by Lexington Partners L.P., the lead investor in the project. MIM also plans to utilize $250 million on new private equity opportunities. The successful closing of this fund highlights MIM&#39;s expanding capabilities and leadership in private markets. This strategic move follows the strong performance of MetLife&#39;s private equity investments, which, at first quarter-end, held $14.3 billion in assets.
The private equity team of MIM alone has invested more than $20 billion in alternative investments in the 2010-2023 period. The deal was advised by Evercore, and it further underscores MIM&#39;s commitment to offer tailored investment solutions to institutional investors around the globe. It had $593.7 billion in assets under management as of the first quarter-end.
This move will likely expand MIM&#39;s private equity platform and attract more institutional investors, boosting MetLife&#39;s assets under management and overall financial growth. The overall resilience of the economy offers a stable backdrop for launching new investment vehicles.
Investors are seeking diversification and strong returns in private equity, maintaining high demand for such investments among institutional investors. Given the strong long-term performance of MIM&#39;s private equity investments, this seems like an opportune moment to leverage its track record.
<h3>Price Performance</h3>
MetLife&#39;s shares have gained 20.9% in the past year compared with the 21.6% growth of the industry it belongs to.
<img alt="Zacks Investment Research" src="https://staticx-tuner.zacks.com/images/articles/charts/73/70804.jpg?v=1840979077" />
Image Source: Zacks Investment Research
<h3>Zacks Rank &amp; Key Picks</h3>
MetLife currently has a Zacks Rank #3 (Hold).
Investors interested in the broader&nbsp;Finance&nbsp;space may look at some better-ranked players like Root, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/root#NASDAQ">ROOT</a>), Brown &amp; Brown, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/bro#NYSE">BRO</a>) and EverQuote, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ever#NASDAQ">EVER</a>). While Root currently sports a Zacks Rank #1 (Strong Buy), Brown &amp; Brown and EverQuote carry a Zacks Rank #2 (Buy) each.
The consensus mark for ROOT&#39;s current-year earnings indicates a 60.6% year-over-year improvement. It beat earnings estimates in all the past four quarters, with an average surprise of 34.1%. Furthermore, the consensus estimate for Root&#39;s 2024 revenues suggests 125.3% year-over-year growth.
The Zacks Consensus Estimate for Brown &amp; Brown&#39;s current-year earnings is pegged at $3.61 per share, which indicates 28.5% year-over-year growth. It has witnessed one upward estimate revision against none in the opposite direction during the past 60 days. BRO beat earnings estimates in each of the past four quarters, with an average surprise of 11.9%.
The consensus mark for EverQuote&#39;s current-year earnings indicates a 103.3% year-over-year improvement. It beat earnings estimates in all the past four quarters, with an average surprise of 65.2%. Furthermore, the consensus estimate for EVER&#39;s 2024 revenues suggests 33.9% year-over-year growth.
<a href="https://www.zacks.com/stock/news/2298720/metlife-met-arm-mim-secures-1-2b-for-2nd-private-equity-fund?cid=CS-BENZ-FT-analyst_blog|company_news_finance_sector-2298720">To read this article on Zacks.com click here.</a>

Small Cap

ROOT

MetLife Arm MIM Secures $1.2B for 2nd Private Equity Fund

Old Republic International Corporation&#39;s (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ori#NYSE">ORI</a>) solid market presence, niche focus, low property catastrophe exposure in its General Insurance segment and strong capital position make it worth adding to one&#39;s portfolio.
<h3>Optimistic Growth Projections</h3>
The Zacks Consensus Estimate for Old Republic&#39;s 2024 earnings per share indicates a year-over-year increase of 3.8%. The consensus estimate for revenues is pegged at $7.96 billion, implying a year-over-year improvement of 6.8%. 
The consensus estimate for 2025 earnings per share and revenues indicates an increase of 4.4% and 4%, respectively, from the corresponding 2024 estimates. 
Earnings have grown 10.3% in the past five years, better than the industry average of 9.2%
<h3>Earnings Surprise History</h3>
Old Republic has a solid record of beating earnings estimates in three of the last four quarters while missing in one, the average being 6.61%.
<h3>Zacks Rank &amp; Price Performance</h3>
ORI currently carries a Zacks Rank #2 (Buy). In the past year, the stock has gained 23.1%, outperforming the industry&#39;s growth of 19.6%.
<img alt="Zacks Investment Research" src="https://staticx-tuner.zacks.com/images/articles/charts/e9/68556.jpg?v=830495571" /> 
Image Source: Zacks Investment Research
<h3>Style Score</h3>
Old Republic has a VGM Score of B. The VGM Score helps identify stocks with the most attractive value, best growth and the most promising momentum. 
Back-tested results have shown that stocks with a VGM Score of A or B combined with a Zacks Rank #1 (Strong Buy) or 2 offer better returns.
<h3>Attractive Valuation</h3>
ORI shares are trading at a price-to-book multiple of 1.30, lower than the industry average of 2.53. The company has a Value Score of B. This style score helps find the most attractive value stocks.
<h3>Business Tailwinds</h3>
ORI&#39;s General Insurance segment should continue to benefit from segmentation, better risk selection, meticulous pricing and increased use of analytics. This, in turn, has helped deliver a combined ratio below 96 for 14 years. The insurer aims combined ratio between 90 and 95. 
The Title business, on the other hand, should continue to benefit from an expanding presence in the commercial real estate market. 
Banking on operational strength, this third-largest title insurer in the country distributes wealth to its shareholders in the form of dividends and share repurchases. ORI has an impressive dividend history banking on operational excellence. It has increased dividends for 43 straight years. It has been paying dividends for the last 83 years, besides paying special dividends occasionally, making it an attractive pick for yield-seeking investors. Its board recently approved a $1.1 billion share buyback program. 
Old Republic International is one of the 111 companies that have posted at least 28 consecutive years of annual dividend growth. The insurer has returned 12.6% per share for the last 10 years to shareholders. 
Return on invested capital in the trailing 12 months was 5.9%, better than the industry average of 2%, reflecting ORI&#39;s efficiency in utilizing funds to generate income.
<h3>Other Stocks to Consider</h3>
Some other top-ranked stocks from the multi-line insurance industry are Lemonade, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/lmnd#NYSE">LMND</a>), EverQuote, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ever#NASDAQ">EVER</a>) and Radian Group Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/rdn#NYSE">RDN</a>), each carrying a Zacks Rank #2 at present. 
Lemonade has a solid track record of beating earnings estimates in each of the trailing four quarters, the average being 12.82%. Shares of LMND have plunged 22.2% in the past year. 
The Zacks Consensus Estimate for LMND&#39;s 2024 and 2025 earnings implies year-over-year growth of 13.5% and 18.3%, respectively. 
EverQuote&#39;s earnings beat estimates in each of the trailing four quarters, delivering an average surprise of 65.16%. Shares of EVER have skyrocketed 171.8% in the past year. 
The Zacks Consensus Estimate for EverQuote&#39;s 2024 and 2025 earnings per share indicates a year-over-year increase of 102.6% and 362.50%, respectively. 
Radian has a solid track record of beating earnings estimates in each of the trailing four quarters, the average being 22.79%. Shares of RDN have climbed 17% in the past year. 
The Zacks Consensus Estimate for RDN&#39;s 2024 and 2025 revenues implies year-over-year growth of 8.2% and 4.9%, respectively.
<a href="https://www.zacks.com/stock/news/2286581/should-you-add-old-republic-ori-stock-for-better-returns?cid=CS-BENZ-FT-analyst_blog|rank_focused-2286581">To read this article on Zacks.com click here.</a>

LMND

Should You Add Old Republic Stock for Better Returns?

B. Riley lowered the firm's price target on EverQuote (EVER) to $29 from $36.50 and keeps a Buy rating on the shares. EverQuote reported a Q3 beat ...

EverQuote price target lowered to $29 from $36.50 at B. Riley

With 2025 on the horizon, investors are sharpening their focus on the year ahead, selecting portfolio additions that aim to bring solid returns. "T...

J.P. Morgan Says These 2 Stocks Are Top Picks for 2025

Conference call with CFO Sanborn will be held on December 9 at 1 pm hosted by JPMorgan. Webcast Link Published first on TheFly – the ultimate sourc...

EverQuote participates in a conference call with JPMorgan

EverQuote: Ripe Buying Moment (Rating Upgrade)

JPMorgan analyst Cory Carpenter raised the firm's price target on Take-Two (TTWO) to $225 from $195 and keeps an Overweight rating on the shares. T...

JPMorgan ups Take-Two price target, names a top 2025 pick

Raymond James analyst Gregory Peters upgraded EverQuote (EVER) to Strong Buy from Outperform with a $35 price target Published first on TheFly – th...

EverQuote upgraded to Strong Buy from Outperform at Raymond James

As previously reported, Raymond James upgraded EverQuote (EVER) to Strong Buy from Outperform with an unchanged price target of $35 in conjunction ...

EverQuote upgraded to Strong Buy at Raymond James on strong expected demand

Raymond James upgrades Progressive on being a core holding for large cap growth investors

The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research calls that investors need...

Progressive, EverQuote upgraded: Wall Street's top analyst calls

Get caught up quickly on the top news and calls moving stocks with these five Top Five lists. 1. STOCK NEWS: Nippon Steel (NPSCY) pushes out expect...

Comments

EverQuote

EverQuote (EVER) Opciones

EverQuote (NASDAQ:EVER) Bolsa, Cadena de Opciones

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL